CDH1 and neoplasm: While there may be a potential role in the clinic, it appears that miR-19a-3p downregulates pro-invasive markers, such as MMP2, MMP9, N-cadherin, Vimentin, and α-SMA, and upregulates the epithelial marker E-cadherin, indicating its impact on tumor aggressiveness through coordinated mechanisms.